CLINICAL_TRIALS
trial_result
· 2016-09-09
Clinical Trial Update: Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation [Phase 3]
Summary
A Phase 3 trial evaluating inhaled nitric oxide to prevent or treat ischemia-reperfusion lung injury in lung transplant patients was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mallinckrodt | Conditions: Ischemia-Reperfusion Injury | Phase 3 | Status: TERMINATED